Biocartis Group NV

Declaration of Voting Results & Voting Rights Announcements • Oct 3, 2023

Start with "groups" of holders. Add subtotals with S, and then finish with the persons who are "alone". For groups, start with the ultimate controlling natural person or legal entity. The totals, subtotals and % will be updated once you have clicked on .

95

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument		Expiration date Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights Settlement
							+
	TOTAL			0	0,00%
The totals will be updated once you have clicked on
	TOTAL (A & B)				# of voting rights % of voting rights
			CALCULATE	3.843.804	4,09%

11) Full chain of controlled undertakings through which the holding is effectively held, if applicable

Jill McManus, Assistant Treasurer, Johnson &

Johnson Innovation - JJDC, Inc. Signature +

DocuSign Envelope ID: 585E5FB4-F352-4D79-A26B-4247F3D445AC

		Form TR-1 BE PART I	Transparency notification
1) Status of the notification
	Final
2) Issuer
Identification number 0505-640-808	Name BIOCARTIS
						0
3) Reason for the notification
	Acquisition or disposal of voting securities or voting rights					+ 2
4) Notification by						0
	A parent undertaking or a controlling person					+ 2
5) Persons subject to the notification requirement						0
	Name
	Johnson & Johnson Johnson & Johnson Innovation - JJDC, Inc. (Delaware)		One Johnson & Johnson Plaza, New Brunswick, New Jersey, USA 08933 410 George Street, New Brunswick, New Jersey, USA 08901			- +
	6) Persons that dispose of voting rights (only to be filled in if art. 7 of the Law applies)
	Name		Address (for legal entities)			+ A
	Please continue entering the information in part II concerning the		Part II
	persons referred to in Sections 5 and 6
7) Date on which the threshold is crossed		15/09/2023 (DD/MM/YYYY)
8) Threshold that is crossed (in %)
	3
	If the holding has fallen below the lowest threshold, you have the option of not entering any numbers in Section 10
9) Denominator
	93.915.910 Please enter the denominator before filling in the data
10) Notified details
A) Voting rights	Previous notification # of voting rights		After the transaction # of voting rights		% of voting rights
Holders of voting rights			Linked to securities Not linked to the securities	Linked to securities	Not linked to the securities	S
Johnson & Johnson Johnson & Johnson Innovation - JJDC, Inc. (New Jersey) (no longer in	0 3.843.804	0 0	0 0	0,00% 0,00%	0,00% 0,00%	- 1 - 1
existence) Johnson & Johnson Innovation - JJDC, Inc. (Delaware)		3.843.804	0	4,09%	0,00%	+ 1
	TOTAL	3.843.804	0	4,09%	0,00%
	Start with "groups" of holders. Add subtotals with S, and then finish with the persons who are "alone". For groups, start with the ultimate controlling natural person or legal entity. The totals, subtotals and % will be updated once you have clicked on .
B) Equivalent financial instruments			After the transaction
				# of voting rights that may be
Holders of equivalent financial instruments	Type of financial instrument		Expiration date Exercise period or date	acquired if the instrument is exercised	% of voting rights	Settlement
						+
	TOTAL The totals will be updated once you have clicked on			0	0,00%
	TOTAL (A & B)		CALCULATE	3.843.804	# of voting rights % of voting rights 4,09%
	11) Full chain of controlled undertakings through which the holding is effectively held, if applicable
	Johnson & Johnson Innovation - JJDC, Inc. (Delaware) is a wholly owned subsidiary of Johnson & Johnson (NYSE: JNJ). Johnson & Johnson is not a controlled entity.
12) In case of proxy voting for only one GM
						(DD/MM/YYYY)
Holder		will cease to hold / will hold again	0		voting rights as of
13) Additional information
	On 12 November 2021, Johnson & Johnson (NYSE: JNJ), the parent company of (former entity) Johnson & Johnson Innovation – JJDC, Inc. ("Old JJDC"), announced its intent to separate and spin off its consumer health business into a new publicly traded company, Kenvue Inc., which completed its initial public offering on 8 May 2023. In connection with this separation, Old JJDC (which was organized as a New Jersey corporation) has merged with and into a newly-formed Delaware corporation (which has the same name as Old JJDC, such name being "Johnson & Johnson Innovation – JJDC, Inc."), with
	such Delaware corporation being the surviving entity under the merger ("New JJDC"). As a result of the aforementioned merger, Old JJDC's equity interests in Biocartis Group NV have been transfered to New JJDC by operation of law. The aforementioned merger has taken place on 15 September 2023.
	Done at New Brunswick, NJ USA
On		27/09/2023 (DD/MM/YYYY)
	Marc Larkins, Office of Corporate Secretary, Johnson
	& Johnson		Signature